| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |